Struggling with frequent bathroom trips or a weak urine stream? Learn how to manage BPH with personalized care, from ...
A new study underway at St. David’s Surgical Hospital could help men recover faster and live a better quality of life after ...
Scientists uncover a molecular weakness that could transform prostate cancer therapy. An international team of researchers has identified a new weakness in prostate cancer cells that could enhance ...
Prostate cancer is an issue that impacts patients differently. Thankfully, their different treatment options help patients in ...
The former president spoke publicly for the first time since completing a round of radiation therapy for an aggressive form ...
Certification opens the European market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., /PRNewswire/ -- ...
IS THE PRINCIPAL INVESTIGATOR IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PA / ACCESS Newswire / October 22, 2025 / Medicus Pharma Ltd. (NASDAQ:MDCX) (“Medicus” or the “Company”), a biotech/life ...
ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, presented posters at the 2025 EORTC-NCI ...
Cerezen is the first and only device certified under the new EU framework. The US FDA is a bit slower to approve it.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback